Steve Miller, Chief Operating Officer at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 40,000 shares at $0.55 ($22K) on 2012-07-03, disclosed to the SEC on 2012-07-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.55 | 12,300 | $7K | 30.8% |
| 2 | $0.55 | 27,700 | $15K | 69.3% |
| Total | $0.55 avg | 40,000 | $22K | 100% |
| Filing → |
| CPRX | SELL | 2024-08-22 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |